Metastatic Hormone Sensitive Prostate Cancer
2 competing products in clinical development for Metastatic Hormone Sensitive Prostate Cancer.
Pipeline by Phase
Phase 32
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Enzalutamide + Placebo + Androgen deprivation therapy (ADT) | Astellas Pharma | Phase 3 | Active | 44 |
| Enzalutamide + Placebo | Astellas Pharma | Phase 3 | Completed | 40 |